Clinically node-positive bladder cancer: oncological results of induction chemotherapy and consolidative surgery
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F18%3A00078014" target="_blank" >RIV/00209805:_____/18:00078014 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/18:00104048
Result on the web
<a href="http://dx.doi.org/10.4149/neo_2018_170403N239" target="_blank" >http://dx.doi.org/10.4149/neo_2018_170403N239</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4149/neo_2018_170403N239" target="_blank" >10.4149/neo_2018_170403N239</a>
Alternative languages
Result language
angličtina
Original language name
Clinically node-positive bladder cancer: oncological results of induction chemotherapy and consolidative surgery
Original language description
Patients with clinically node-positive bladder cancer have a poor prognosis, with many receiving only palliative chemotherapy. We evaluated oncological results in bladder cancer patients with clinically regional and supraregional lymphadenopathy treated with induction chemotherapy (IC) and consolidative cystectomy. Twenty-five patients with clinically node-positive bladder cancer (including pelvic and retroperitoneal nodes) were treated with 2-4 cycles of IC followed by consolidative cystectomy between 2010 and 2016. Pathologic complete response (pCR) was defined as no residual tumor in the final specimen (ypT0N0). The 3-year cancer-specific (CSS) and recurrence-free survival (RFS) for the whole cohort were 52% and 39%, respectively. The 3-year RFS differed according to volume of nodal metastases, the rates were 56% for minimal nodal disease (cN1) versus 33% for cN2-3 and 0% for cM1 disease (p<0.001). pCR was seen in 7 (28%) patients; 50% in cN1 versus 13% in cN3-M1. pCR associated with 3-year CSS of 80% versus 45% in patients with persistent disease after IC. In conclusion, a multimodal approach to patients with clinically node-positive bladder cancer, consisting of IC followed by consolidative surgery, may achieve long-term survival in selected patients. Better results may be expected in patients with initially minimal nodal burden and complete pathologic response to chemotherapy. Further studies are warranted to improve patient selection for consolidative surgery, especially with supra-regional metastases.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Neoplasma
ISSN
0028-2685
e-ISSN
—
Volume of the periodical
65
Issue of the periodical within the volume
2
Country of publishing house
SK - SLOVAKIA
Number of pages
5
Pages from-to
287-291
UT code for WoS article
000435149800016
EID of the result in the Scopus database
2-s2.0-85044241893